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Abstract
Oxidative stress is implicated in the pathogenesis of diabetic nephropathy (DN) but out-
comes of many clinical trials are controversial. To define the role of antioxidants in kidney
protection during the development of diabetic nephropathy, we have generated a novel
genetic antioxidant mouse model with over- or under-expression of lipoic acid synthase
gene (Lias). These models have been mated with Ins2Akita/+ mice, a type I diabetic mouse
model. We compare the major pathologic changes and oxidative stress status in two new
strains of the mice with controls. Our results show that Ins2Akita/+ mice with under-
expressed Lias gene, exhibit higher oxidative stress and more severe DN features (albu-
minuria, glomerular basement membrane thickening and mesangial matrix expansion). In
contrast, Ins2Akita/+ mice with highly-expressed Lias gene display lower oxidative stress
and less DN pathologic changes. Our study demonstrates that strengthening endogenous
antioxidant capacity could be an effective strategy for prevention and treatment of DN.
Introduction
Alpha-lipoid acid (1, 2-dithiolane-3-pentanoic acid, LA) is a potent antioxidant produced in
mitochondria by lipoic acid synthase (LIAS) [1]. Among all natural antioxidants, LA plays a
central role in the antioxidant network. It has several unique characteristics that include: 1)
serving as a powerful antioxidant in both the oxidized and reduced forms; 2) quenching of a
variety of reactive oxygen species (ROS); and 3) regenerating other antioxidants such as oxi-
dized vitamins C and E, coenzymeQ10 and glutathione [2, 3]. LA is also a cofactor for several
mitochondrial enzymes such as pyruvate dehydrogenase complex and α-ketoglutarate dehy-
drogenase complex, both of which participate in energy generation [4]. Complete lack of the
Lias gene leads to mouse embryonic death, further underscoring the pivotal role LA plays in
antioxidant defense and as a metabolic requirement [5].
Diabetic nephropathy (DN) is a leading cause of end-stage renal disease [6]. Oxidative stress
has been suggested to play an important role in the development of DN [7, 8]. On the basis of
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epidemiological evidence, antioxidant therapy is a plausible strategy for treatment of this oxi-
dative stress-related disease. However, there are conflicting reports regarding the effect of
chronic dietary supplementation with antioxidants on outcomes of diabetic kidney disease in
clinical trials [9–12]. An explanation for these observations is that natural genetic variation
leads to inter-individual variations with respect to basic endogenous antioxidant levels. Indeed,
it is well known that natural genetic variation affects gene expression levels and thus impacts
molecular and physiological phenotypes such as protein expression levels. As a consequence,
different endogenous antioxidant levels in tested individuals may influence experimental
results and outcome of clinical trials aimed at examining the impact of antioxidant therapy on
disease course. Thus, we hypothesize that the extent of oxidative damage is mainly dependent
on endogenous antioxidant levels, especially in the initiation stage of diseases in which oxida-
tive stress is implicated. To test our hypothesis, we have generated a group of unique lipoic acid
hypomorphic and hypermorphic antioxidant mice by geneticallymodifying the 3’-untranslated
region (3’-UTR) of lipoic acid synthase; this strategy is a similar approach that has been previ-
ously reported [13]. By comparing the major parameters of DN and oxidative stress in Ins2A-
kita/+ type 1 diabeticmice with different levels of endogenous Lias gene expression, we sought
to define the role of oxidative stress in the onset and development of DN and obtain a better
understanding of impact of antioxidants.
Materials and Methods
Creation of LiasLow/+ and LiasHigh/+ Mice by Changing 3’ untranslated
region (3’-UTR) Sequences
The targeting construct prior to recombination consisted of a 3’-UTR of the endogenous Lias
gene and was replaced after recombination with a cassette. The cassette consisted of the 3’-
UTR sequences of bovine growth hormone gene (bGH) and a Neo gene, two lox P sites flanking
the two fragments, and followed by the 3’-UTR of cFos gene. Colonies surviving after selection
with G418 and ganciclovir were first screened by PCR with the following primers: a common
primer (50-CTA AAG TGT AGC CAAGCCCT-30), a primer for screening Lias 3’-UTR (50-C
CT CCTCAG CTA CTG ACA TT-30), a primer for bGH 3’-UTR (50-GAG GCA AAC AAC
AGA TGG CT-3’) and a primer for cFos 3’-UTR (50-CTTCTC TGA CTG CAG ATC CT-3’).
Targeted Embryonic stem (ES) cells were identified by the presence of approximately 200 bp
PCR product for bGH 3’-UTR, and 300 bp after Cre recombinase-mediated recombination.
Germline recombination was achieved using the B6.FVB-Tg (EIIa-Cre) stock (JAX#3724).
These results were confirmed by Southern blot analysis.
The hypomorphic (LiasLow/Low) and hypermorphic (LiasHigh/High) Liasmice in C57BL/6
genetic background, with 25% or 150% of wildtype Lias gene expression respectively, were
mated with C57BL/6-Ins2Akita/+ diabeticmice (JAX#3548), an established mouse model of type
I diabetes mellitus [14, 15]. The Ins2Akita/+ mice have a mutation changing cysteine 96 to tyro-
sine in the insulin 2 gene and exhibit marked hyperglycemia as early as 4 weeks of age [15].
Eight B6-LiasLow/LowIns2Akita/+ males and 9 B6-LiasHigh/HighIns2Akita/+ males were obtained
from crossing C57BL/6-Ins2Akita/+ female mice and LiasLow/Low or LiasHigh/High male mice.
Only males were phenotyped in this study because Ins2Akita/+ females on the B6 genetic back-
ground displayed much less severe diabetic phenotype than the males [16]. Lias+/+Ins2Akita/+
mice served as a control. In addition, the mice were fed normal mouse chow (Research Diets,
Inc. New Brunswick, NJ) and had ad libitum access to autoclaved water. All animal protocols
were approved by the University of North Carolina at Chapel Hill Institutional Animal Care
and Use Committee (Protocol numbers: 13-208-0 and16-153-0).
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Hydroxynonenal; Sod2, superoxide dismutase 2;
Tgfβ1, transforming growth factor β1; Nrf2, nuclear
factor (erythroid-derived 2)-like 2; Nox4, NADPH
oxidase 4.
Biochemical Parameters
Blood glucose was monitored monthly in the mice from 7 to 28 weeks using the One-Touch
Lifescanmeter (Lifescan Inc, Milpitas, CA) on samples obtained after a 5-hour fasting period.
Plasma glucose, total cholesterol and triglyceridewere examined using assay kits (Wako, Rich-
mond, VA). Lactic acid concentration in tissues was determined as described [17]. Pyruvate
concentration was measured using a pyruvate assay kit (BioVision, Mountain View, CA).
Urinary Albumin Excretion
At 28 weeks of age, individual mice were placed in metabolic cages to record food consump-
tion, water intake, body weight, and urine output for 48 hours prior to sacrifice.Urine albumin
in LiasHigh/High Ins2Akita/+ and LiasLow/LowIns2Akita/+ mice was assessed by ELISA using Albu-
well according to the manufacturer’s instructions (Exocell, Philadelphia, PA). Urinary creati-
nine levels were determined by the Creatinine Kit (Exocell) according to the manufacturer’s
instructions.
Urinary MCP-1 assay
Urinary monocyte chemoattractant protein-1 (MCP-1) excretion was measured as markers of
renal inflammation. The MCP-1 concentration was measured using an ELISA assay kit
(Research & Diagnostic Systems, Minneapolis, MN) according to the manufacturer’s instruc-
tions. The ELISA kit was specific for mouseMCP-1 and sensitive down to 2 pg/ml. The MCP-1
concentration was normalized to the urinary creatinine concentration.
Blood Pressure Measurement
Systolic blood pressure (BP) was determined in conscious mice using a tail-cuffmethod [18].
The first 10 readings were discarded, and 30 readings were taken to obtain daily BP. Average
BP on 5 consecutive days was taken to represent BP of each mouse.
Renal Function and Morphometric Analyses
Mice were perfused at 120 mmHg with 0.9% saline containing heparin, followed by 4% para-
formaldehyde and then embedded in paraffin and 3-μm sections were cut. Sectionswere
stained with hematoxylin and eosin (H&E) and Periodic acid-Schiff 'sbase (PAS) for examina-
tion by light microscopy. Mesangial matrix expansion (MME) was examined in a blinded fash-
ion and scored from 0 to 4 according to the ratio of glomerular expansion area/normal area:
score 0, a normal glomerulus; score 1, increasedmesangial matrix<25% of glomerular tuft;
score 2, MME of 25%–50% of glomerular tuft; score 3, MME of 50%–75%; and score 4, MME
of>75% of the tuft. MME was derived from assessment of three glomerular profiles on each
mouse. Next, the kidney cortex was conventionally prepared for transmission electronmicros-
copy. The samples were examined with an electronmicroscope (Model LEO 910; LEO Electron
Microscopy Inc, Thornwood, NY). Three to four kidney samples from each experimental
group were randomly chosen for electronmicroscopic observation. Thickness of glomerular
basement membranes (GBM) was measured from transmission electronmicroscopy photos
(magnification, x12,000) at 5 specific points along each of 10 randomly selected glomerular
capillaries to determine an average GBM thickness for 5 mice in each group. Mitochondrial
damage in proximal tubules was examined in each genotypic group. Briefly, under the same
magnification (x10,000), about 200–300 mitochondria from 10–12 randomly selected fields in
each genotypic group were observed.The Degree of the mitochondrial damage was assessed
according to the following scale from 0 to 3: 0) indicating a normal structure, 1) normal with
Impact of Antioxidant Gene Change on Diabetic Nephropathy
PLOS ONE | DOI:10.1371/journal.pone.0163208 October 5, 2016 3 / 16
slight swelling, 2) mitochondrial swelling and cristae dilated/disorder, and 3) mitochondrial
vacuolization. On the basis of the above criteria, the degree of mitochondrial damage in the dif-
ferent groups of mice were scored and the total scores of mitochondria per group were summa-
rized and then divided by total counted mitochondrion number in each group to get the ratio
of damaged over total counted mitochondrion number. The ratio indicates the degree of mito-
chondrial damage.
Assessment of Oxidative Stress
To evaluate oxidative stress, the concentration of urinary 8-isoprostane was measured using an
enzyme immunoassay and expressed relative to the level of urine creatinine following the man-
ufacturer’s protocol (Cayman Chemical Inc., Ann Arbor, MI). Systemic oxidative stress in
bloodwas determined using 4-Hydroxynonenal (4-HNE) assay kit in accordance with manu-
facturer’s specifications (Cell Biolabs, Inc. San Diego, CA).
Western Blot Analysis
Total protein was extracted from the renal cortical tissues with RIPA buffer and protein con-
centration was determined by BCAprotein assay method (Thermo Scientific, Rockford, IL) fol-
lowing manufacturer’s instructions.Western blot analysis was performed using a rabbit
polyclonal antibody against mouse LIAS (GeneTex, Inc.Irvine, CA), and (voltage-dependent
anion-selective channel protein 1) VDAC1 as mitochondrial loading control (Abcam, Cam-
bridge, MA) and the protein bands were quantified with Image Quant LAS4000 software (GE
Healthcare, Piscataway, NJ).
Reverse Transcription and Quantitative Real-Time Polymerase Chain
Reaction (RT-PCR)
Total RNA was extracted from kidney cortex using an ABI 6700 Automated Nucleic Acid
Workstation following the manufacturer’s protocol (Applied Biosystems, Foster City, CA). Rel-
ative mRNA amounts were determined using real-time quantitative reverse transcriptase-PCR
(Applied Biosystems) with β-actin as the reference gene in each reaction [18]. The expression
of the genes Lias, superoxide dismutase 2 (Sod2), transforming growth factor β1 (Tgfβ1),
nuclear factor (erythroid-derived2)-like 2 (Nrf2) and NADPH oxidase 4 (Nox4) were
examined.
Statistical Analyses
Data were expressed as mean ± standard error of the mean (SEM). P<0.05 was considered
significant.P values are obtained for comparisons among LiasLow/LowIns2Akita//+, LiasHigh/High
Ins2Akita/+ and Lias+/+Ins2Akita/+ mice using one-way or two-way ANOVA. Post hoc pairwise
comparisons were performed by Tukey–Kramer honestly significant differences (HSD) test
(JUM, SAS Institute, Cary, NC).
Results
Model Construction
As described in methods, the gene targeting strategy for engineering the hyper- and hypo-
morphic Liasmice with over- or under-expression of the Lias gene was based on genetic modi-
fication of the 3’-UTR (Fig 1A). The DNA sequence result showed that the orientation of the
3'UTR sequences of both bGH and c-Fos are replaced in the transcriptional orientation (data
not shown). ES cell lines with a correctly targeted 3’-UTR were identified and injected into
Impact of Antioxidant Gene Change on Diabetic Nephropathy
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C57BL/6J recipient blastocysts, which were transferred to the uteri of CD-1 pseudopregnant
dams. These mice initially produced stabilized transcripts of the Lias gene using the 3’-UTR
sequence of bGH, but were changed to unstable transcripts using the 3’-UTR from the cFos gene
after Cre-LoxP recombination was induced. The LiasHigh/+ mice were crossed with Tg (Ella-cre)
mice that expressed Cre-recombinase in testis and thus the homozygous offspring (LiasLow/Low)
generated from these LiasLow/+ founder males expressed low levels of Lias. Since plasma and tis-
sue LA were not directlymeasured due to a technical difficulty [19], changes in organ LA levels
were inferred by demonstrating changes in Lias gene expression using RT-PCR (Fig 1B) orWest-
ern blot (Fig 1C).Western blot results for kidney LIAS, quantitatively assessed by densitometry,
showed that LIAS protein concentrations were about 150% in LiasHigh/High mice and around 25%
in LiasLow/lowmice, compared with those in Lias+/+mice (Fig 1D).
Systemic Pathological Changes
The hypomorphic (LiasLow/Low) and hypermorphic (LiasHigh/High) Liasmice, with 25% or 150%
of wildtype Lias gene expression, respectively, were mated with Ins2Akita/+ diabeticmice, an
Fig 1. Characterizations of the new mouse model. (A) Generation of mice with genetically graded expression of
lipoic acid synthase (Lias). Wild type (top line): Endogenous Lias gene 3’-UTR (white column) is located after exon
11 of Lias gene. The targeting construct (second line): consisted of the 3’-UTR sequences of bovine growth
hormone (bGH) gene and a Neo gene, two lox P sites flanking the two fragments, and followed by the 3’-UTR of
cFos gene and thymidine kinase gene (TK). H/H (third line): The locus after homologous recombination. Lias
expression is now controlled by the 3’-UTR of bGH, which stabilizes Lias mRNA. L/L (bottom line): The locus after
Cre-lox P recombination. Lias expression is controlled by the 3-UTR of cFos, which destabilizes the Lias mRNA.
(B) The kidney mRNA levels of Lias in 12-week-old L/L, H/H and WT male mice and in 28-week-old diabetic L/L, H/
H and WT male mice. Lias gene expression in the non-diabetic WT mice as a reference for the all six groups of
mice. (C) Lipoic acid synthase (LIAS) concentrations of kidney cortex mitochondria, measured by Western blot,
and VDAC1 as loading control, in 12-week-old L/L, H/H and WT male mice. n = 5, in each group. (D) The amounts
of lipoic acid in non-diabetic LiasHigh/High and LiasLow/Low kidney, detected by Western blot, were quantified by
Image Quant software. Data are expressed as the mean ± SE.
doi:10.1371/journal.pone.0163208.g001
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establishedmouse model of diabetes mellitus that can mimic early stages of DN [14, 15]. Lia-
sHigh/High Ins2Akita/+ and LiasLow/LowIns2Akita/+ mice exhibited the different diabetic phenotypes.
LiasLow/LowIns2Akita/+ mice had significantly lower body weight compared to both LiasHigh/High-
Ins2
Akita/+
and Lias+/+Ins2Akita/+ mice as shown in Table 1 (P<0.05). Both LiasHigh/HighIns2Akita/+
and LiasLow/LowIns2Akita//+ mice manifested hyperglycemia at 28 weeks of age but there was no
significant difference between the two groups of mice. In addition, plasma total cholesterol
and triglyceride levels were similar among LiasHigh/HighIns2Akita/+, LiasLow/LowIns2Akita/+, and
Lias+/+Ins2Akita/+ mice (Table 1).
Kidney Pathologic Changes
Urinary albumin/creatinine ratio in LiasLow/LowIns2Akita/+ mice was 2.6-fold higher than Lias+/+
Ins2Akita/+ mice at 28 weeks of age whereas, the ratio in LiasHigh/HighIns2Akita/+ mice was about 30%
lower than Lias+/+Ins2Akita mice but was not statistically significant (Fig 2). Dietary intake and
water consumption in LiasLow/LowIns2Akita/+ and LiasHigh/HighIns2Akita/+ mice were not significantly
different compared with Lias+/+Ins2Akita mice (Table 1). The ratio of kidneyweight-to-bodyweight
(KW/BW) in LiasLow/LowIns2Akita/+ mice was higher than control Lias+/+Ins2Akita/+ mice whereas
this ratio was lower in LiasHigh/HighIns2Akita/+ mice than in control Lias+/+Ins2Akita/+ mice. Kidney
levels of lactate and pyruvate were similar in all three diabetic groups (Table 1).
Renal pathological changes were assessed by light and transmission electronmicroscopy. Mod-
erate mesangial matrix expansion, as evidencedby increased accumulation of PAS positivemate-
rial in the mesangial area, was observed in 28-week-old LiasLow/LowIns2Akita/+ mice (Fig 3A),
whereasmesangial expansion was milder in LiasHigh/HighIns2Akita/+ mice (Fig 3C), compared to
the Lias+/+Ins2Akita control (Fig 3B). Semi-quantitative analysis of PAS-stained kidney sections
revealed a highermesangial expansion score (P<0.05) in LiasLow/LowIns2Akita/+ mice as compared
with LiasHigh/HighIns2Akita/+ and Lias+/+Ins2Akita/+ mice (Fig 3D). Electronmicroscopic examina-
tion showed thickening of the GBM in LiasLow/LowIns2Akita/+ mice (Fig 4A), compared to Lias+/+
Ins2Akita/+ mice (Fig 4C). Quantitative examination using Image J showed the thickening of the
GBM significantly increased (0.36 ± 0.04 μm versus 0.27 ± 0.04 μm in, P<0.05, Fig 4G). Foot pro-
cess effacement was primarily detected in LiasLow/LowIns2Akita/+ mice (Fig 4A) but podocyte slit
pore width did not exhibit significant differences among three groups of the mice. Considerable
numbers of mitochondria within proximal tubules in LiasLow/LowIns2Akita/+ mice were damaged as
revealed by mitochondrial structural irregularitieswith swelling, disruption of cisternae and
vacuolization. In contrast, few damagedmitochondria were observed in LiasHigh/HighIns2Akita/+
mice (Fig 4B and 4E) compared with LiasLow/LowIns2Akita/+ and Lias+/+Ins2Akita/+ mice (Fig 4D
and 4F). Damagedmitochondria were quantified in LiasHigh/HighIns2Akita/+ and Lias+/+Ins2Akita/+
mice at 28 weeks of age. As shown in Fig 4H, the average number of damagedmitochondria in
proximal tubules of LiasLow/LowIns2Akita/+ mice were significantly increasedwhereas damaged
mitochondria in LiasHigh/HighIns2Akita/+ mice were significantly decreased compared to Lias+/+
Ins2Akita/+ mice. Glomerulosclerosis, arteriolar hyalinosis and focal tubulointerstitial fibrosis were
not detectable in all diabetic Ins2Akita/+ mice at 28 weeks of age regardless of Lias transcript level.
In addition, no electron dense deposits were observed in the glomeruli in all mice.
Oxidative Stress and Inflammation
Systemic oxidative stress, assessed by measuring 4-HNE, a well-known product of lipid peroxi-
dation and a measure of oxidative stress, was significantly different in LiasHigh/HighIns2Akita/+
and Lias+/+Ins2Akita/+ mice compared with Lias+/+Ins2Akita/+ mice (Fig 5A). Another reliable
lipid peroxidation marker, 8-isoprostane, was examined in urine. LiasLow/LowIns2Akita/+ mice at
28-weeks-old showed noticeably higher levels than Lias+/+Ins2Akita/+ mice (Fig 5B). On the
Impact of Antioxidant Gene Change on Diabetic Nephropathy
PLOS ONE | DOI:10.1371/journal.pone.0163208 October 5, 2016 6 / 16
contrary, LiasHigh/HighIns2Akita/+ mice manifested significantly lower urinary 8-isoprostane lev-
els than Lias+/+Ins2Akita/+ mice (Fig 5B).
Consistent withWestern blot results for LIAS protein, RT-PCR analysis of kidney cortex
showed significantly increasedLias gene expression in LiasHigh/HighIns2Akita/+ and significantly
reduced expression in LiasLow/LowIns2Akita/+ mice at 28 weeks of age (Table 2). Interestingly, gene
expression of mitochondrial Sod2, a major antioxidant enzymewhich responds to enhanced super-
oxide production inmitochondria, was significantly higher in LiasLow/LowIns2Akita/+ mice, likely
reflecting an attempt to compensate for reduced LIAS-generated LA in LiasLow/LowIns2Akita/+
Table 1. Laboratory data in experimental animals.
Parameters LiasH/HIns2Akita/+ n = 9 Lias+/+Ins2Akita/+n = 10 LiasL/LIns2Akita/+ n = 8 P Value (ANOVA)
Systolic pressure (mmHg) 106±9 113±8 119±12 0.18
Diet intake (g/day) 8.4±0.6 7.6±0.6 9.4±0.8 0.27
Water intake (ml/day) 23.5±0.6 23.8±1.3 26.5±0.8 0.24
Body weight (BW, g) 29.6±1.1 26.7±1.1 22.6±1.5 <0.05
Plasma
Glucose (mg/dl) 554±17 544±15 529±21 0.55
Cholesterol (mg/dl) 64±13 78±7 84±13 0.60
Triglyceride (mg/dl) 52±5 55±9 63±13 0.47
Kidney
Urine volume (ml/day) 21.5±8.0 22.5±4.2 25.3±6.7 0.33
Kidney weight (KW, mg) 230±16 250±14 260±17 0.25
KW/BW (mg/g) 8.3±1.4 9.3±1.3 11.5±0.9 0.13
lactate (mM/mg protein) 0.87±0.10 1.14±0.11 1.26±0.18 0.09
pyruvate (mM/mg protein) 2.6±0.31 2.6±0.22 2.2±0.28 0.85
Data shown are mean values ±SEM for the male mice at 28 weeks.
P values are for comparisons among LiasLow/LowIns2Akita//+, LiasHigh/HighIns2Akita/+ mice and Lias+/+Ins2Akita/+ mice using one way ANOVA.
doi:10.1371/journal.pone.0163208.t001
Fig 2. Changes of urine albumin in the mice. Urine albumin/creatinine ratio in LiasLow/LowIns2Akita//+ mice is
significantly elevated (P<0.01) whereas the ratio in LiasHigh/HighIns2Akita/+ mice is reduced but does not reach
significance, compared with Lias+/+Ins2Akita/+ mice at 28 weeks of age. The numbers inside the bars indicate the
number of animals.
doi:10.1371/journal.pone.0163208.g002
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kidney. The data confirmour previous observation that Sod2 expression alsomarkedly increases in
Lias+/-Ins2Akita/+ mice [20]. To identify the ROS sources, we examinedNox4 gene expression in
kidney cortex. Our result showed thatNox4 gene expression was significantly increased at
28-weeks of age in LiasLow/LowIns2Akita/+ whereas a significant decrease in LiasHigh/HighIns2Akita/+
kidney suggests that NADPH oxidase is a target for the antioxidant effects of lipoic acid (Table 2).
Fig 3. Changes of Lias gene expression influences mesangial matrix expansion (MME). Representative
PAS staining of glomeruli in diabetic Ins2Akita//+ mice at 28 weeks of age. (A) LiasLow/LowIns2Akita//+ mice. (B)
Lias+/+Ins2Akita/+ mice. (C) LiasHigh/HighIns2Akita/+ mice. Original magnification x400, Bars = 50μm. (D) MME
score, quantified as the region of positive PAS staining, is expressed as a function of total glomerular tuft area.
The numbers inside the bars indicate the number of animals. LiasLow/LowIns2Akita//+ and LiasHigh/HighIns2Akita/+
mice are compared with Lias+/+Ins2Akita/+ mice. Values are expressed as the mean ±SEM.
doi:10.1371/journal.pone.0163208.g003
Fig 4. Representative electron micrographs from diabetic Ins2Akita//+ mice at 28 weeks of age. (A)
Segmentally thickened glomerular basement membrane (GBM) with minor irregularities along the lamina rara
externa (“undulations”) and segmental podocyte foot process effacement in LiasLow/LowIns2Akita//+ mice. Original
magnification, x8,000. (B) LiasHigh/HighIns2Akita/+ mice. Original magnification, x8,000. (C) Lias+/+Ins2Akita/+ mice.
Original magnification, x8,000. (D) Illustrated is the basal part of a tubular epithelial cell containing distorted
mitochondria. Cristae are disrupted and mitochondria filled presumably with lipid products vaguely resembling
zebra-bodies in LiasLow/LowIns2Akita//+ mice. Original Magnification, x5,000. (E) A small number of damaged
mitochondria in proximal tubular cells of LiasHigh/HighIns2Akita/+ mice. Original magnification, x8,000. (F)
Damaged mitochondria in proximal tubular cells of Lias+/+Ins2Akita/+ mice. Magnification, x8,000. (G) Electron
microscopic quantitative examination using Image J showed thickening of the GBM significant increase in
LiasLow/LowIns2Akita/+ mice compared to Lias+/+Ins2Akita/+ mice. (H) Ratio of average damaged mitochondrion
over entire counted mitochondria in proximal tubules of LiasLow/LowIns2Akita//+, LiasHigh/HighIns2Akita/+ and Lias+/+
Ins2Akita/+ mice, using one-way ANOVA for the comparison.
doi:10.1371/journal.pone.0163208.g004
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In addition, significantly reducedTgfβ1gene expression in LiasHigh/HighIns2Akita mice (Table 2) sug-
gests that increasedLias gene expression likely attenuates adverse effect(s) of TGF-β1.
NRF2 is a key transcription factor for regulation of antioxidant defense [21] and LA has
been shown to stimulate NRF2 nuclear accumulation [22]. To test whether endogenous LA can
affect NRF2, we examinedNrf2 gene expression in 28-week-old LiasLow/LowIns2Akita/+ and Lia-
sHigh/HighIns2Akita/+ mouse kidney. Unlike Sod2,Nox4 and Tgfb1 transcripts, no significant
changes inNrf2 expression were observed in response to Lias gene manipulation (Table 2).
Inflammation is thought to be a pathogenic factor in the initiation of DN and monocyte
chemoattractant protein-1 (MCP-1) is considered as a major mediator of inflammation in DN
patients. To further probe the underlyingmechanism(s) of endogenous oxidant injury in rela-
tion to inflammation in diabetes mellitus, we measured urinaryMCP-1. Our results showed
that there were significantly increased urinaryMCP-1 levels in LiasLow/LowIns2Akita/+ mice com-
pared with Lias+/+Ins2Akita/+ and LiasHigh/HighIns2Akita/+ mice (Fig 6).
Discussion
In our previous study, the pathologic changes of diabetic nephropathy (DN) were exacerbated
in Lias+/-Ins2Akita/+ mice with an approximately 50% reduced Lias gene expression, and the
aforementioned pathology was associated with significantly enhanced oxidative stress [20]. To
verify the central role of LIAS in generating endogenous LA for antioxidant defenses, we
Fig 5. Alternated oxidative stress. (A). Oxidative stress in kidney cortex is associated with plasma concentration of lipid
perioxidation marker, 4-hydroxynonenal (4-HNE), in diabetic Ins2Akita//+ mice and non-diabetic mice with differential Lias gene
expression. Lias+/+ mice as a control. Data were analyzed using two-way ANOVA. (B). Urine 8-isoprostane varies with Lias
expression in diabetic mice. Data were analyzed using one-way ANOVA. The numbers inside the bars indicate the number of
animals in each group. Results are expressed as mean ±SEM.
doi:10.1371/journal.pone.0163208.g005
Table 2. Gene expression in kidney cortex.
LiasH/HIns2Akita/-n = 10 Lias+/+Ins2Akita/-n = 10 LiasL/LIns2Akita/-n = 7
Lias 1.39±0.23aa 1.00±0.14 0.19±0.05aa
Sod2 1.05±0.25 1.00±0.16 1.65±0.21a
Tgfβ1 0.67±0.16a 1.00±0.11 1.32±0.19
Nrf2 1.23±0.22 1.00±0.15 0.86±0.2
Nox4 0.57±0.15a 1.00±0.16 1.94±0.26aa
Samples were taken at 7 months of age of the mice. Data shown are mean values ±SEM using t-test.
a: P<0.05 vs Lias+/+Ins2Akita/+ mice.
aa: P<0.01 vs Lias+/+Ins2Akita/+ mice mRNA levels of Lias+/+Ins2Akita/+ mice were used as references and set to 1.00
doi:10.1371/journal.pone.0163208.t002
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manipulated Lias transcript stability to generate two lines of novel antioxidant mousemodels. In
one, Lias gene expression was reduced to roughly 25% of normal, a level sufficient to maintain
viability (Lias null mice are embryonic lethal). In the other, Lias gene expression was increased to
approximately 150% of normal expression level, which is anticipated to afford better protection,
than wildtypemice, against oxidative stress. When combined with the diabetogenic Ins2Akita
mutation, the double mutants allow evaluation of the impact of two different antioxidant base-
lines (Low or High) on the development of DN. As hypothesized, the new diabeticmodels exhib-
ited divergent renal responses to diabetogenic stress when compared with Lias+/+Ins2Akita/+ mice.
Major DN pathological changes such as albuminuria and mesangial expansion in LiasLow/LowIn-
s2
Akita/+
mice were significantly worse than those in Lias+/+Ins2Akita/+ mice whereas the two patho-
logical changes were less severe in LiasHigh/HighIns2Akita/+ mice. The data further support the
correlation betweenLias transcript abundance and inferred endogenous LA concentration;
levels of two reliable common oxidative stress biomarkers, plasma 4-NHE and urine 8-isopros-
tane, were both significantly higher in LiasLow/LowIns2Akita/+ mice and significantly lower in Lia-
sHigh/HighIns2Akita/+ mice compared to Lias+/+Ins2Akita/+ controls. These results are consistent
with our previous data where we used different lipid peroxidationmarkers, like TBARS and, anti-
oxidant marker such as ratio of GSH/GSSG to reveal significantly increased oxidative stress and
decreased endogenous antioxidant capacity in Lias+/-Ins2Akita/+ mice. Since lipoic acid plays a
central role in the antioxidant network, the significantly increased oxidative stress and decreased
endogenous antioxidant capacity observed in Lias+/-Ins2Akita/+ mice were very likely due to the
impairment of the antioxidant defense system. In addition, our data demonstrate that Lias over-
expression effectively attenuates albuminuria and kidney disorders without exerting a significant
hypoglycemic effect in LiasHigh/HighIns2Akita/+ mice, suggesting that the protective effect of LA
results primarily from its antioxidant capacity rather than from a direct hypoglycemic effect.
These findings confirm that LIAS-generated lipoic acid plays a vital role in the early development
of DN by demonstrating that diabeticmice with low endogenous antioxidant capacity manifestly
increasedROS-mediated renal stress. In particular, the newmodels provide very strong proof-of-
principle that an increased antioxidant reservoir could represent a powerful new tool in the
Fig 6. Kideny inflammation. Urinary MCP-1 levels in LiasLow/LowIns2Akita/+, Lias+/+Ins2Akita/+ and LiasHigh/
HighIns2Akita/+ mice. The numbers inside the bars indicate the number of animals in each group. Results are
expressed as mean ±SEM.
doi:10.1371/journal.pone.0163208.g006
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prevention and / or treatment of diabetic kidney disease. A novel finding obtained from our cur-
rent study underlines the importance of antioxidants for mitochondrial protection in the retarda-
tion of DN. Growing evidence indicates that mitochondria play a critical role in the initiation
and development of DN.Mitochondria are believed to be the major organelles involved in super-
oxide generation. They consume approximately 85% of the oxygen used by cells and overproduc-
tion of superoxide anions may occur by excessive electron leak in the mitochondrial electron
transport chain during diabetes [21]. On the other hand, mitochondria are the primary targets
for oxidative stress because they lack protection from histone and are incapable of performing
DNA repair functions by themselves [22]. Our previous observations have shown that the num-
ber of damagedmitochondrion in kidney proximal tubules was significantly higher in Ins2Akita/+
mice with 50% of reduced Lias gene expression than Lias+/+Ins2Akita/+ littermate controls. In
the current studies, we consolidate our previous observation that mitochondrial damage in proxi-
mal tubules is a predominant pathological feature of DN by demonstrating that reduction in
Lias gene expression in LiasLow/LowIns2Akita/+ mice and increased Lias expression in LiasHigh/High-
Ins2
Akita/+
mice impact mitochondrial integrity and function. Through use of in vitro LIAS knock-
down studies it has been reported that ROSmay decrease the mitochondrialmembrane potential
[23]. Given that mitochondrial dysfunction is postulated to be an initiator for diabetic complica-
tions [24], we presume that attenuation of DN by endogenous LA is likely, through preservation
of mitochondrial function, to mediate reduction in mitochondrial ROS and mitochondrial dam-
age. Thus, strengtheningmitochondrial antioxidant capacity could be an effectivemeans for pre-
vention and treatment of DN. Our results are similar to a recent report indicating that Ins2Akita/+
mice specifically overexpressing catalase, a key antioxidant enzyme in renal proximal tubular
cells, had reduced renal oxidative stress and attenuated progression of DN without changing
blood glucose concentration [25]. Our contention, that mitochondrial damage mediates DN and
that lipoic acid mitigates this injury, is further supported by another recent report that Ins2Akita/+
derived β-cells have increasedmitochondrial dysfunction, oxidative stress, mitochondrial DNA
damage, and alterations in mitochondrial protein levels that contribute to β-cell dysfunction
[26].
LIAS synthesizes lipoic acid in mitochondria. Lipoic acid has a high reductive capacity and
actively participates in the recycling of vitamin C and E. Diabetes mellitus is characterized by
increased oxidative stress that negatively impacts mitochondrial integrity and function.Hence
the physiologic importance of LIAS in diabetes is through its role in lipoic acid synthesis; lipoic
acid may play a vital role in mitochondrial protection from oxidative stress and thus maintain
energy balance during diabetes. Our previous data obtained from in Lias+/-Ins2Akita/+ mice
showed that systemic and urinary oxidative stress markers significantly increased, whereas
endogenous antioxidant capacity significantly decreased,when Lias gene expression levels was
approximately 50%. Furthermore, reduced Lias gene expression in Lias+/-Ins2Akita/+ mice was
associated with more severe DN pathological changes compared with Lias+/+Ins2Akita/+ mice.
In particular, a large number of damaged mitochondria were detected in mouse proximal
tubule epithelial cells as a unique phenomenon. The results observed in LiasLow/LowIns2Akita/+
mice have confirmed that reduced Lias gene expression leads to decreased endogenous antioxi-
dant capacity and mitochondrial damage in the proximal tubules. On the other hand, in Lia-
sHigh/HighIns2Akita/+ mice harboring increased Lias gene expression, endogenous oxidant
capacity and mitochondrial integrity are protected. Our data also indicate that kidney proximal
tubules can serve as a window via which alternation of mitochondrial status due to oxidative
stress can be assessed in diabetic nephropathy.
Based on ours and, other investigator’s data [23], we propose that several mechanisms are
involved in the changes of kidney Lias expression and LA levels under diabetic conditions:
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1. Excess ROS generated in diabeticmellitus impairs the antioxidant defense system, indicated
by decline of reduced GSH levels, leading to further accumulation of ROS. The latter is
reflected by a significantly enhanced lipid peroxidation levels in body and urine. Our new
animal model with low expression of Lias gene further highlights this relationship between
endogenous antioxidant levels, ROS concentrations and DN pathologic changes. That is,
low endogenous antioxidant capacity will result in high levels of ROS and more severe DN.
2. Excessive ROS in diabetes mellitus damages mitochondria.Mitochondria are a major site of
ROS generation and are vulnerable targets for ROS; hence, accumulated ROS due to insuffi-
cient LA protection in LiasLow/LowIns2Akita/+ mice could damage mitochondria.We found
that significantmitochondrial damage in LiasLow/LowIns2Akita/+ mice; other investigators
have also demonstrated decreasedmitochondrial membrane potential using in vitro LASY
knockdownmethod [23].
To investigate the mechanisms through which lipoic acid protects mitochondria in kidney
proximal tubules, we examined gene expression of several common antioxidant enzymes in
kidney cortex, including Sod series and glutathione peroxidase. Our data, using these novel
mouse models, identify Sod2 as an antioxidant target by showing that expression of Sod2 (a
major antioxidant enzyme which responds to enhanced superoxide production in mitochon-
dria) markedly increases in kidney cortex of LiasLow/LowIns2Akita/+ mice; the latter observation
has been previously reported in the Lias+/-Ins2Akita/+ diabeticmice with 50% reduced LIAS
[20]. SOD2 co-exists with Lias in mitochondria and is a major antioxidant enzyme that
responds to enhanced superoxide production in mitochondria; hence, the observation that
SOD2 increases in kidney cortex of LiasLow/LowIns2Akita/+ mice with increased ROS is not
surprising.
We attempted to identify antioxidant targets of LA in the diabetic kidney cortex. In addition
to dysfunctionalmitochondria, one of the most prominent sources of ROS is from the
NADPH oxidase (NOX) activity [27–29]. Amongst these, theNox4 gene, a biomarker of oxida-
tive stress in the diabeticmellitus, has particularly high expression in the kidney [30]. Our
result showed that Nox4 gene expression was significantly increased in LiasLow/LowIns2Akita/+
and decreased in LiasHigh/HighIns2Akita/+ kidney cortex, respectively, suggesting that NADPH
oxidase 4 is an antioxidant target of lipoic acid.
NRF2 is a key transcription factor for regulation of antioxidant defense [31]. Although it
has been reported that LA stimulated NRF2 nuclear accumulation [32], our result do not detect
any significant changes of Nrf2 gene expression in 28-week-old LiasLow/LowIns2Akita/+ and Lia-
sHigh/HighIns2Akita/+ mouse kidney. Hence, the renal protective actionmediated by increased
LIAS-generated LA is not accompanied by Nrf2 transcription alternation.
Several studies have revealed increased expression of TGF-β1 in renal glomeruli in experi-
mental models of diabetes [34]. TGF-β1 is a critical mediator of podocyte injury and kidney
hypertrophy characteristic of DN [33]. Thus, significantly reducedTgfβ1gene expression in
LiasHigh/HighIns2Akita mice may play a role in attenuation of the adverse effect of diabetes melli-
tus on kidney structure and function. In addition, our results obtained from previous and the
current studies using different degrees of Lias deficiencymouse models have clearly demon-
strated that renal proximal tubules, with numerous mitochondria required for their important
absorption functions, are sensitive to mitochondrion damage and that they are an ideal region
of the nephron for assessment of mitochondria status during development of diabetic nephrop-
athy. It is also worth studying the impact of mitochondrial damage on resorption in order to
ascertainwhich mitochondrial component(s) is/are injured and the mechanism through which
the deficiency of endogenous antioxidant protection develops.
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Accumulating evidence support a role for inflammation in DN. In particular, the inflamma-
tory cells infiltrate (like increased renal macrophage infiltration) and significantly higher levels of
cytokines (chemokines) includingmonocyte chemoattractant protein-1 (MCP-1), accompanies
DN [35]. MCP-1 is considered as a major mediator of inflammation process in DN patients [36].
It is a member of the CC chemokine family synthesized by a variety of cell types including glo-
merular endothelial cells, mesangial cells, tubular epithelial cells, and monocytes [37]. Studies
suggest that MCP-1 production in mesangial cells and renal tubular epithelial cells are induced
by advanced glycated end products (AGEs) throughNF-κB activation [38, 39]. The promoters
of MCP-1 gene contain binding sites for NF-kB [40]. Since urinaryMCP-1 is upregulated in
many renal diseases, including DN patients, we measured urinaryMCP-1 levels in the three
groups of mice. Our results showed that there were significantly increased urinaryMCP-1 levels
in LiasLow/LowIns2Akita/+ mice compared with Lias+/+Ins2Akita/+ and LiasHigh/HighIns2Akita/+ mice.
This observation indicates that increased inflammation occurs in LiasLow/LowIns2Akita/+ mice. The
increasedMCP-1 is likely mediated by NF-kB in response to enhanced kidney oxidative stress
[41, 42]. This result provides further evidence that increasing the endogenous antioxidant capac-
ity could be an effective strategy for prevention and treatment of DN.
In a previous study, we showed that plasma glucose levels in Lias+/-Ins2Akita/+ mice are sig-
nificantly greater than those in Lias+/+Ins2Akita/+ mice [20]. However, we did not detect any sig-
nificant differences among the three groups of mice in the current study. We believe genetic
background of the mice plays a major role in this discrepancy [43, 44]. We usedmice with B6
genetic background for the current project, whereas we used F1 genetic background for the
previous one. Thus, it is likely that even the same level of Lias gene expression in the different
genetic background could exhibit different traits.
In summary, our data clearly indicate that LiasHigh/HighIns2Akita/+ and LiasLow/LowIns2Akita/+
mice manifest variations in levels of endogenous antioxidant capacity in kidneys that lead to
different degrees of diabetic pathologic changes. The results have clarified the role of antioxi-
dants in the early development of diabetic nephropathy and strongly suggest that protection of
mitochondria is a novel therapeutic target for effective antioxidant therapy of DN.
We conclude that these new antioxidant mouse models are suitable to elucidate the contri-
butions of oxidative stress in the pathogenesis of diabetic kidney disease.
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